NS

Neha Srivastava

Active Director Director DIN 05294803
DIN 05294803 First appointment Nov 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Neha Srivastava

Data last updated:

Neha Srivastava is a Director at Neromed Pharmaceuticals Private Limited (since 2018). The company operates in Trading. Neromed Pharmaceuticals Private Limited reported revenue of ₹33.4 Lakh (FY 2021).

DIN 05294803
Primary Designation Director
Industry Trading
First Appointment 14 Nov 2018
Oldest Company Age 7 yrs
Largest company Neromed Pharmaceuticals Private Limited · ₹33.4 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Nov 20182018₹33.4 Lakh (FY 2021)Active

Board colleagues of Neha Srivastava

NameDINCompanyDesignation
Rohan Srivastava07156798Neromed Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neromed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neha Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neha Srivastava

Neha Srivastava currently holds 1 directorship: Neromed Pharmaceuticals Private Limited (Director, since 14 Nov 2018, revenue ₹33.4 Lakh (FY 2021)).

Neha Srivastava was first appointed on 14 Nov 2018 as Director at Neromed Pharmaceuticals Private Limited.

The current boards of Neha Srivastava's companies include Rohan Srivastava (Neromed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available